What is the best treatment for hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Treatment for Hypogonadism

Testosterone replacement therapy (TRT) is the first-line treatment for hypogonadism, with intramuscular testosterone formulations recommended as the initial treatment due to their established efficacy and lower cost compared to transdermal options. 1

Diagnosis Confirmation

Before initiating treatment, diagnosis should be confirmed with:

  • Morning total testosterone levels < 300 ng/dL on at least two separate occasions 1
  • Comprehensive hormonal evaluation including LH and FSH measurements 1
  • Assessment of baseline hemoglobin, hematocrit, and cardiovascular risk factors 1

Treatment Algorithm

First-Line Treatment: Testosterone Replacement Therapy (TRT)

  1. Intramuscular testosterone formulations

    • Recommended as initial treatment due to:
      • Similar clinical effectiveness to other formulations
      • Considerably lower cost compared to transdermal options
      • Established efficacy for improving sexual function 1
    • Monitoring: Testosterone levels should be measured midway between injections 1
  2. Transdermal preparations (gels and patches)

    • Alternative first-line option, especially when stable day-to-day levels are preferred 1
    • Application site for testosterone 2% gel: front and inner thighs 2
    • Low volume application may be preferred by some patients 2
  3. Dose adjustment based on pre-dose morning testosterone levels:

    • 750 ng/dL: Decrease daily dose by 20-25%

    • 350-750 ng/dL: No change
    • <350 ng/dL: Increase daily dose by 20-25% 1

Alternative Treatments (When Fertility Preservation is Desired)

  1. Gonadotropin therapy

    • Start with human chorionic gonadotropin (hCG) alone
    • Add follicle-stimulating hormone (FSH) if needed
    • Treatment of choice when fertility preservation is required 1, 3
  2. Clomiphene citrate (CC)

    • Off-label use for hypogonadism with fertility preservation
    • Increases endogenous testosterone production 1, 3
    • Note: Data supporting efficacy on hypogonadal symptoms are insufficient 3
  3. Selective estrogen receptor modulators (SERMs)

    • Alternative for functional central hypogonadism
    • Can significantly increase testosterone levels 1, 3
    • Use is off-label and should not be routine clinical practice 3

Monitoring Protocol

  • Testosterone levels: After starting treatment and every 6-12 months
  • Target level: Mid-normal range (450-600 ng/dL) 1
  • Hemoglobin/hematocrit: Discontinue if Hct >54% 1
  • PSA: Monitor according to guidelines; consider discontinuation if significant increase 1, 4
  • Efficacy assessment: Evaluate symptom improvement after 3-6 months 1

Contraindications and Precautions

Absolute Contraindications

  • Prostate cancer
  • Breast cancer
  • Desire for near-term fertility
  • Severe sleep apnea
  • Uncontrolled heart failure
  • Recent cardiovascular events 1

Relative Contraindications

  • History of hepatocellular carcinoma
  • Thrombosis
  • Other cardiovascular risk factors 1

Common Adverse Effects

  • Erythrocytosis (dose-dependent: 2.8-17.9%)
  • Suppression of spermatogenesis
  • Peripheral edema
  • Emotional lability 1, 4, 5
  • Skin reactions (with transdermal preparations) 4, 2

Special Considerations

  1. Fertility concerns:

    • TRT suppresses spermatogenesis and can cause oligospermia or azoospermia 1, 6
    • For men interested in current or future fertility, consider gonadotropins, SERMs, or aromatase inhibitors 1, 6, 7
  2. Lifestyle modifications:

    • Weight loss through low-calorie diets and physical activity can reverse obesity-associated secondary hypogonadism 1
    • Consider as first-line approach for metabolic benefits
    • Combining lifestyle changes with TRT may yield better outcomes in symptomatic patients 1
  3. Geriatric patients:

    • May be at increased risk for developing prostatic hypertrophy and carcinoma 5
    • Careful monitoring required in this population 8

Treatment Efficacy

  • TRT provides small but significant improvements in global sexual function and erectile function 1
  • Small improvements in quality of life 1
  • Limited or no effect on physical functioning, depressive symptoms, energy/vitality, and cognition 1
  • All approved testosterone replacement methods, when used according to recommendations, can restore normal serum testosterone concentrations and relieve symptoms in most hypogonadal men 6

References

Guideline

Hypogonadism Due to Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Testosterone Replacement Therapy in Hypogonadal Men.

Endocrinology and metabolism clinics of North America, 2022

Research

Update in testosterone therapy for men.

The journal of sexual medicine, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.